Stock Research for CRL

Featured Broker: Ally Invest

Get the due diligence for another stock.


CRL Stock Chart & Research Data

The CRL chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CRL chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


CRL Due diligence Resources & Stock Charts

The CRL stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View CRL Detailed Price Forecast - CNN Money CNN View CRL Detailed Summary - Google Finance
Yahoo View CRL Detailed Summary - Yahoo! Finance Zacks View CRL Stock Research & Analysis -

Stock Analysis

TradeIdeas View CRL Trends & Analysis - Trade-Ideas Barrons View CRL Major Holders - Barrons
NASDAQ View CRL Call Transcripts - NASDAQ Seeking View CRL Breaking News & Analysis - Seeking Alpha
Spotlight View CRL Annual Report - OTC Report View CRL OTC Short Report -
TradeKing View CRL Fundamentals - TradeKing Charts View CRL SEC Filings - Bar Chart
WSJ View Historical Prices for CRL - The WSJ Morningstar View Performance/Total Return for CRL - Morningstar
MarketWatch View the Analyst Estimates for CRL - MarketWatch CNBC View the Earnings History for CRL - CNBC
StockMarketWatch View the CRL Earnings - StockMarketWatch MacroAxis View CRL Buy or Sell Recommendations - MacroAxis
Bullish View the CRL Bullish Patterns - American Bulls Short Pains View CRL Short Pain Metrics -

Social Media Mentions

StockTwits View CRL Stock Mentions - StockTwits PennyStocks View CRL Stock Mentions - PennyStockTweets
Twitter View CRL Stock Mentions - Twitter Invest Hub View CRL Investment Forum News - Investor Hub
Yahoo View CRL Stock Mentions - Yahoo! Message Board Seeking Alpha View CRL Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for CRL - Insider Cow View Insider Transactions for CRL - Insider Cow
CNBC View CRL Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for CRL - OTC Markets
Yahoo View Insider Transactions for CRL - Yahoo! Finance NASDAQ View Institutional Holdings for CRL - NASDAQ

Stock Charts

FinViz View CRL Stock Insight & Charts - StockCharts View CRL Investment Charts -
BarChart View CRL Stock Overview & Charts - BarChart Trading View View CRL User Generated Charts - Trading View

Latest Financial News for CRL

Charles River Laboratories Awarded Five-Year, $95.7 Million Contract by the National Institute of Allergy and Infectious Diseases
Posted on Tuesday October 16, 2018

Charles River Laboratories International, Inc. (CRL) today announced that it was awarded a five-year, $95.7 million contract by the National Institute of Allergy and Infectious Diseases (NIAID), which is one of the largest institutes of the National Institutes of Health (NIH). Under NIAID’s Division of Intramural Research animal care program, Charles River will manage and provide staffing for NIAID’s on-site vivarium and related research model operations. The program is required to ensure the humane care and use of research models, and the efficient management of NIAID’s research model operations.

See what the IHS Markit Score report has to say about Charles River Laboratories International Inc.
Posted on Thursday October 11, 2018

Charles River Laboratories International Inc NYSE:CRL

Charles River Laboratories Schedules Third-Quarter 2018 Earnings Release and Conference Call
Posted on Wednesday October 10, 2018

Charles River Laboratories International, Inc. will release third-quarter 2018 financial results on Wednesday, November 7th, before the market opens. A conference call has been scheduled to discuss this information on Wednesday, November 7th, at 8:30 a.m.

Cancer center CEO leaves Merck board after disclosure scandal
Posted on Tuesday October 02, 2018

The New York Times previously reported Thompson's resignation from Merck and from lab services company Charles River Laboratories International Inc. The move follows the resignation of Sloan Kettering's chief medical officer, Jose Baselga, in September, after a New York Times and Pro Publica investigation revealed that he had not disclosed millions of dollars in payments from health-care companies in many of his research articles.

Stock Market & Investing Books

Enter a stock symbol to view the stock details.